Concepedia

Supannika Sorin

SS

Statistics

Publications

5

Citations

90

H-Index

5

Active since

2019

Affiliations

Kumamoto University(Current)

Khon Kaen University

Taipei Medical University

Supannika Sorin is an author at Kumamoto University specializing in oncology, mesenchymal transition, and epithelial-mesenchymal transition markers.

ORCID

Publications per year

2019–2024

5

Publications

5

Terminal fucose mediates progression of human cholangiocarcinoma through EGF/EGFR activation and the Akt/Erk signaling pathway

Somsiri Indramanee, Kanlayanee Sawanyawisuth, Atit Silsirivanit et al. · Scientific Reports · 2019 · 28 citations · Full text

, , +13

Liraglutide exhibits potential anti-tumor effects on the progression of intrahepatic cholangiocarcinoma, in vitro and in vivo

Ronnakrit Trakoonsenathong, Waritta Kunprom, Chaiwat Aphivatanasiri et al. · Scientific Reports · 2024 · 21 citations · Full text

, , +16

Emerging roles of GALNT5 on promoting EGFR activation in cholangiocarcinoma: a mechanistic insight.

Marutpong Detarya, Worachart Lert-itthiporn, Panupong Mahalapbutr et al. · PubMed · 2022 · 18 citations · Full text

, , +17

γ-aminobutyric acid B2 receptor: A potential therapeutic target for cholangiocarcinoma in patients with diabetes mellitus

Charupong Saengboonmee, Supannika Sorin, Sakkarn Sangkhamanon et al. · World Journal of Gastroenterology · 2023 · 12 citations · Full text

, , +16

Chromatin modifier Hmga2 promotes adult hematopoietic stem cell function and blood regeneration in stress conditions

Sho Kubota, Yuqi Sun, Mariko Morii et al. · The EMBO Journal · 2024 · 11 citations · Full text

, , +17

1–5 of 5